Global Seminar Held with Invited Medical Professionals

Inibio announced on June 23 that it successfully concluded the global medical aesthetics conference, ‘AMWC Korea 2026,’ which was held at the Grand InterContinental Parnas in Gangnam, Seoul, from June 19 to 20.


At this academic conference, Inibio participated as a Diamond Sponsor, operating an independent booth and hosting a sponsor symposium. The company also received the ‘Best Injectable for Skin Enhancement’ award.

Inibio Successfully Concludes Participation in AMWC Korea 2026 View original image

During the symposium, in-depth discussions were held under the theme ‘Clinical Diversification of CCUG7968-Derived Botulinum Toxin, Inivo.’ Dr. Lee Wonki, Director of Beautique Clinic, introduced facial treatment indications and strategies for combination therapy with hyaluronic acid (HA) products. Dr. Hwang Seungkuk, Director of Seven Days Plastic Surgery, shared his clinical experience on the potential for expanding indications to non-facial areas, including calf procedures.


On June 17, Inibio invited medical professionals and partners from key countries such as Brazil, China, and Peru to hold the ‘Inivo Global Experts Meeting.’ Participants visited Inibio’s production facility in Bucheon and acquired hands-on procedure know-how through a live seminar at a domestic medical institution.


On the final day of the event, Inibio hosted ‘Inivo Night,’ bringing together domestic and international partners in one place, thereby strengthening partnerships beyond academic exchange.



An Inibio official stated, “We will continue to enhance our brand presence in the global market through ongoing academic activities and international cooperation.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing